Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.46 |
| ▸ | GABRP | O00591 | 2/20 | 0.41 |
| ▸ | GABRD | O14764 | 2/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.41 |
| ▸ | GABRE | P78334 | 2/20 | 0.41 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.41 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.41 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1236551 | 1.00 | ALOX15 (0.56) | ALOX15BLMPMP22KMT2ASLC7A5 | |
| SCHEMBL5322012 | 0.89 | KMT2A (0.48) | ALOX15BLMPMP22KMT2ASLC7A5 | |
| SCHEMBL4716019 | 0.84 | GABRP (0.60) | BLMKMT2ASLC7A5GABRPGABRD | |
| SCHEMBL23420704 | 0.83 | SLC7A5 (0.46) | ALOX15BLMPMP22KMT2ASLC7A5 | |
| Glutamine SCHEMBL1537391 | 0.81 | KMT2A (0.66) | ALOX15BLMPMP22KMT2ASLC7A5 | |
| Glutamine SCHEMBL1537394 | 0.81 | KMT2A (0.66) | ALOX15BLMPMP22KMT2ASLC7A5 | |
| Glutamine SCHEMBL1537469 | 0.81 | KMT2A (0.66) | ALOX15BLMPMP22KMT2ASLC7A5 | |
| Glutamine SCHEMBL1446882 | 0.81 | KMT2A (0.66) | ALOX15BLMPMP22KMT2ASLC7A5 | |
| Glutamine SCHEMBL5053194 | 0.81 | KMT2A (0.66) | ALOX15BLMPMP22KMT2ASLC7A5 | |
| Glutamine SCHEMBL1537468 | 0.81 | KMT2A (0.66) | ALOX15BLMPMP22KMT2ASLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | KARYON-CTT LTD (FI) | 2007-11-08 | — | — | US | disclosed |
| WO-2007113385-A1 | DIAGNOSTIC AND THERAPEUTIC AGENTS | KARYON-CTT LTD (FI) | 2007-10-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070258899-A1 | Diagnostic and therapeutic agents | YBX1, MLX, TPX2 | ALOX15 4182/4885BLM 2573/4885PMP22 990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.